Goldman Sachs Sees Nuplazid Label Expansion for Acadia Pharmaceuticals (ACAD), Reiterates Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq futures slip on chip weakness; S&P 500 holds gains
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Goldman says this FX trade is the best hedge for the AI drawdown
| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 21.47 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.47 | 52 Week High | $42.49 | |||
| Open | $21.47 | 52 Week Low | $16.64 | |||
| Day High | $21.47 | P/E | N/A | |||
| Day Low | $21.47 | EPS | $-0.42 | |||
| Volume | 2,263 | |||||
